Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2154494> ?p ?o }
Showing triples 1 to 71 of
71
with 100 triples per page.
- Q2154494 subject Q7108202.
- Q2154494 subject Q7335338.
- Q2154494 subject Q8229476.
- Q2154494 subject Q8808701.
- Q2154494 subject Q9052323.
- Q2154494 abstract "Riociguat (BAY 63-2521, trade name Adempas) is a novel drug (by Bayer) that is a stimulator of soluble guanylate cyclase (sGC). Clinical trials have looked at riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.".
- Q2154494 atcPrefix "C02".
- Q2154494 atcSuffix "KX05".
- Q2154494 casNumber "625115-55-1".
- Q2154494 chEBI "76018".
- Q2154494 fdaUniiCode "RU3FE2Y4XI".
- Q2154494 iupacName "Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate".
- Q2154494 thumbnail Riociguat_structure.svg?width=300.
- Q2154494 wikiPageExternalLink index.php?title=Riociguat.
- Q2154494 wikiPageWikiLink Q1128595.
- Q2154494 wikiPageWikiLink Q1153419.
- Q2154494 wikiPageWikiLink Q1201019.
- Q2154494 wikiPageWikiLink Q14859627.
- Q2154494 wikiPageWikiLink Q14864419.
- Q2154494 wikiPageWikiLink Q152051.
- Q2154494 wikiPageWikiLink Q15328584.
- Q2154494 wikiPageWikiLink Q185269.
- Q2154494 wikiPageWikiLink Q189621.
- Q2154494 wikiPageWikiLink Q191521.
- Q2154494 wikiPageWikiLink Q2014808.
- Q2154494 wikiPageWikiLink Q207843.
- Q2154494 wikiPageWikiLink Q220599.
- Q2154494 wikiPageWikiLink Q2300099.
- Q2154494 wikiPageWikiLink Q26513.
- Q2154494 wikiPageWikiLink Q271727.
- Q2154494 wikiPageWikiLink Q3045009.
- Q2154494 wikiPageWikiLink Q30612.
- Q2154494 wikiPageWikiLink Q317053.
- Q2154494 wikiPageWikiLink Q323936.
- Q2154494 wikiPageWikiLink Q3408223.
- Q2154494 wikiPageWikiLink Q390551.
- Q2154494 wikiPageWikiLink Q390709.
- Q2154494 wikiPageWikiLink Q408068.
- Q2154494 wikiPageWikiLink Q41509.
- Q2154494 wikiPageWikiLink Q417106.
- Q2154494 wikiPageWikiLink Q418251.
- Q2154494 wikiPageWikiLink Q422511.
- Q2154494 wikiPageWikiLink Q424153.
- Q2154494 wikiPageWikiLink Q5120172.
- Q2154494 wikiPageWikiLink Q5133746.
- Q2154494 wikiPageWikiLink Q6589727.
- Q2154494 wikiPageWikiLink Q706.
- Q2154494 wikiPageWikiLink Q7108202.
- Q2154494 wikiPageWikiLink Q7212330.
- Q2154494 wikiPageWikiLink Q725307.
- Q2154494 wikiPageWikiLink Q7335338.
- Q2154494 wikiPageWikiLink Q7558945.
- Q2154494 wikiPageWikiLink Q7817.
- Q2154494 wikiPageWikiLink Q7920323.
- Q2154494 wikiPageWikiLink Q8229476.
- Q2154494 wikiPageWikiLink Q8808701.
- Q2154494 wikiPageWikiLink Q9052323.
- Q2154494 atcPrefix "2.0".
- Q2154494 atcSuffix "KX05".
- Q2154494 casNumber "625115".
- Q2154494 chebi "76018".
- Q2154494 iupacName "Methyl N-[4,6-Diamino-2-[1-[methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate".
- Q2154494 unii "RU3FE2Y4XI".
- Q2154494 type ChemicalSubstance.
- Q2154494 type Drug.
- Q2154494 type ChemicalObject.
- Q2154494 type Thing.
- Q2154494 type Q8386.
- Q2154494 comment "Riociguat (BAY 63-2521, trade name Adempas) is a novel drug (by Bayer) that is a stimulator of soluble guanylate cyclase (sGC). Clinical trials have looked at riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.".
- Q2154494 label "Riociguat".
- Q2154494 depiction Riociguat_structure.svg.